Trials that use: Logistic regression
New to this method? Read the tutorial →
5,900 results
- Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003): Complete Statistical AnalysisIndependent statistical analysis of Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04254978).
- Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE): primary endpoint results, effect estimate…
- Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations: Complete Statistical AnalysisIndependent statistical analysis of Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II): Complete Statistical AnalysisIndependent statistical analysis of Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05285137).
- Study of Cellutome System for Treatment of Individual Lesions in EB Pts: Complete Statistical AnalysisIndependent statistical analysis of Study of Cellutome System for Treatment of Individual Lesions in EB Pts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): Complete Statistical AnalysisIndependent statistical analysis of Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): primary endpoint results, effect estimate with…
- Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years: Complete Statistical AnalysisIndependent statistical analysis of Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders: Complete Statistical AnalysisIndependent statistical analysis of Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone: Complete Statistical AnalysisIndependent statistical analysis of Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab: Complete Statistical AnalysisIndependent statistical analysis of Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05204290).
- Study of Copanlisib in Hepatic or Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study of Copanlisib in Hepatic or Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03172884).
- Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies: primary endpoint results, effect estimate with…
- Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit: Complete Statistical AnalysisIndependent statistical analysis of Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci: Complete Statistical AnalysisIndependent statistical analysis of Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) – Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants: Complete Statistical AnalysisIndependent statistical analysis of Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01719744).
- Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01942837).
- Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Everolimus (RAD001) in Combination With Lenalidomide: Complete Statistical AnalysisIndependent statistical analysis of Study of Everolimus (RAD001) in Combination With Lenalidomide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01218555).
- Study of EXPAREL in Patients Undergoing Breast Augmentation: Complete Statistical AnalysisIndependent statistical analysis of Study of EXPAREL in Patients Undergoing Breast Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01582490).
- Study of Fampridine-SR Tablets in Multiple Sclerosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Fampridine-SR Tablets in Multiple Sclerosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483652).
- Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL): Complete Statistical AnalysisIndependent statistical analysis of Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration: Complete Statistical AnalysisIndependent statistical analysis of Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00187135).
- Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Gardasil in Mid-Adult Males (MAM): Complete Statistical AnalysisIndependent statistical analysis of Study of Gardasil in Mid-Adult Males (MAM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01432574).
- Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Glycopyrronium in Axillary Hyperhydrosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Glycopyrronium in Axillary Hyperhydrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02530281).
- Study of GSK2586881 on Acute Hypoxia and Exercise: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK2586881 on Acute Hypoxia and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03000686).
- Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate…
- Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…